The Central Role of Gastrointestinal-Specific Anxiety in Irritable Bowel Syndrome: Further Validation of the Visceral Sensitivity Index
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The Visceral Sensitivity Index (VSI) was developed as the first instrument to assess gastrointestinal-specific anxiety, the cognitive, affective, and behavioral response to fear of gastrointestinal sensations, symptoms, and the context in which these visceral sensations and symptoms occur. The purpose of the current study was to a) replicate the previously reported psychometric properties of the VSI, b) assess the known-groups and concurrent validity of the instrument, and c) test conceptual hypotheses regarding gastrointestinal-specific anxiety in comparison to other general measures of psychological distress as a crucial mechanism (mediator/moderator) underlying irritable bowel syndrome diagnosis and its symptoms. METHODS: Two undergraduate student samples (n > 500) were administered the VSI along with measures assessing presence of lower gastrointestinal symptoms, nongastrointestinal pain, health-service utilization, anxiety, depression, vitality, neuroticism, and anxiety sensitivity. Path analyses tested the hypothesis that gastrointestinal-specific anxiety mediates the relationship between affective variables and irritable bowel syndrome diagnosis and symptoms. A 'known-groups' validity approach elucidated the relevance of gastrointestinal-specific anxiety across a spectrum of irritable bowel syndrome patients. RESULTS: Good concurrent, divergent and discriminant validity was demonstrated. Logistic regression revealed that gastrointestinal-specific anxiety is the key explanatory variable of irritable bowel syndrome diagnostic status. Path analysis demonstrated that gastrointestinal-specific anxiety mediates the relationship between general psychological distress measures and gastrointestinal symptom severity. The VSI was related to gastrointestinal, but not nongastrointestinal, symptom severity. CONCLUSIONS: Overall, the VSI demonstrated excellent psychometric properties providing further support for its use in mechanistic studies of the role of anxiety in irritable bowel syndrome presentation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The scale has good internal consistency (Cronbach's α = 0.93) and validity (Labus et al., 2007).”
From Pilot study of acceptance and commitment therapy for irritable bowel syndrome: A preliminary analysis of treatment outcomes and processes of change. (2018) · cites this paper as Labus et al., 2007
In the citing paper
“GSA is a key feature in IBS symptom maintenance, by acting as an endogenous stressor, and higher levels of GSA have consistently been shown to be related to higher symptom severity and lower quality of life (Jerndal et al., 2010;Labus et al., 2004Labus et al., , 2007)).”
From Pilot study of acceptance and commitment therapy for irritable bowel syndrome: A preliminary analysis of treatment outcomes and processes of change. (2018) · cites this paper as Labus et al., 2007
In the citing paper
“It is based on the proposed central role of symptom-related fear and associated avoidance behaviors in IBS [24].”
In the citing paper
“Several studies have confirmed the impact of symptom-related fear and avoidance behaviors on symptom severity and quality of life in IBS [24,27-30].”
In the citing paper
“and most notably it has been shown to be a key explanatory variable in predicting IBS diagnostic status [24].”
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
A comparison of methods to test mediation and other intervening variable effects
MacKinnon, D. P., Lockwood, C. M., Hoffman, J. M., West, S. G., & Sheets, V. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.1.83 · Cited by 9,406 · cited 1×
“powerful method for testing intervening effects (38).”
Foundations of Behavioral Research
Stockton, R., & Kerlinger, F. N. (1974) · American Educational Research Journal · doi:10.2307/1162206 · Cited by 7,347 · cited 2×
“groups of patients might be anticipated to score differently from others (24).”
BackgroundMethodAnxiety, sensitivity, anxiety frequency, and the prediction of fearfulness
Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90143-9 · Cited by 3,169 · cited 1×
“Analogous models of stress sensitivity have been proposed for certain anxiety disorders (3, 4 ) and more recently for chronic somatic pain (5,6).”
BackgroundA revised version of the Psychoticism scale
Eysenck, S. B. G., Eysenck, H. J., & Barrett, P. (1985) · Personality and Individual Differences · doi:10.1016/0191-8869(85)90026-1 · Cited by 3,094
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“Consistent with prevalence estimates in college student samples (39), and comparable to general population estimates ( 40 ), 11% of the individuals met criteria for IBS in both samples.”
ResultPersonality and Individual Differences: A Natural Science Approach
Eysenck, H. J., & Eysenck, M. W. (1985) · Medical Entomology and Zoology · Cited by 1,848
Research works printed but not linked: 3
- Mayer, 2001, J Clin Psychiatry, 62, 28
- Kori, 1990, Pain Manage, 1, 35
- Reiss, 1997, J Anxiety Disorder, 11, 201, 10.1016/s0887-6185(97)00006-6 · DOI
Cited by
THABANE, M., KOTTACHCHI, D. T., & MARSHALL, J. K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03399.x · Cited by 466
Can interoception improve the pragmatic search for biomarkers in psychiatry?
Khalsa, S. S., & Lapidus, R. C. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00121 · Cited by 366
'Gut health': a new objective in medicine?
Bischoff, S. C. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-24 · Cited by 338
“Moreover, scores have been developed and tested which assess particular symptoms, such as pain, using the Functional Bowel Disorder Severity Index or the Numeric Rating Scale [80,81], as well as scores that assess anxiety using the Visceral Sensitivity Index [82].”
Functional Abdominal Pain in Childhood and Long-term Vulnerability to Anxiety Disorders
Shelby, G. D., Shirkey, K. C., Sherman, A. L., Beck, J. E., Haman, K., Shears, A. R., Horst, S. N., Smith, C. A., Garber, J., & Walker, L. S. (2013) · Pediatrics · doi:10.1542/peds.2012-2191 · Cited by 272
Spiegel, B. M. R., Hays, R. D., Bolus, R., Melmed, G. Y., Chang, L., Whitman, C., Khanna, P. P., Paz, S. H., Hays, T., Reise, S., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.237 · Cited by 262
Self-citationLjótsson, B., Falk, L., Vesterlund, A. W., Hedman, E., Lindfors, P., Rück, C., Hursti, T., Andréewitch, S., Jansson, L., Lindefors, N., et al. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.03.003 · Cited by 270
Craske, M. G., Wolitzky-Taylor, K. B., Labus, J., Wu, S., Frese, M., Mayer, E. A., & Naliboff, B. D. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.04.001 · Cited by 243
“93), as well as good convergent, discriminant, content, and predictive validity (Labus et al., 2004; Labus et al., 2007).”
BackgroundMethodSelf-citationBerman, S. M., Naliboff, B. D., Suyenobu, B., Labus, J. S., Stains, J., Ohning, G., Kilpatrick, L., Bueller, J. A., Ruby, K., Jarcho, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2500-07.2008 · Cited by 236
“, 2003), including symptom-related anxiety (Asmundson et al., 1999; Mayer et al., 2001; Goubert et al., 2004; Labus et al., 2007) and central pain amplification (Gracely et al.”
BackgroundSelf-citationLjótsson, B., Hedman, E., Andersson, E., Hesser, H., Lindfors, P., Hursti, T., Rydh, S., Rück, C., Lindefors, N., & Andersson, G. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.139 · Cited by 218
“The treatment is based on the proposed central role of gastrointestinal-specific anxiety (GSA) (”
BackgroundA Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction
Keefer, L., Ballou, S. K., Drossman, D. A., Ringstrom, G., Elsenbruch, S., & Ljótsson, B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.015 · Cited by 213
“…patients with DGBI are characterized by hypervigilance, excessive symptom-speci fi c fear and distress, 64,65 and excessive avoidance behavior, 66 the strong associability of unpleasant and benign visceral sensations might be an ecologically valid target for future research relevant to the…”
BackgroundJerndal, P., Ringström, G., Agerforz, P., Karpefors, M., Akkermans, L. M., Bayati, A., & Simrén, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01493.x · Cited by 192
Fear in the context of pain: Lessons learned from 100 years of fear conditioning research
Meulders, A. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103635 · Cited by 178
Desmedt, O., Heeren, A., Corneille, O., & Luminet, O. (2022) · Biological Psychology · doi:10.1016/j.biopsycho.2022.108289 · Cited by 189
Best practice update: Incorporating psychogastroenterology into management of digestive disorders
Keefer, L., Palsson, O. S., & Pandolfino, J. E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.045 · Cited by 173
“Symptom-specific anxiety can also amplify disease burden and lead to higher health care utilization.(22,23) A survey of 1242 IBS patients(24) found, for example, that a substantial minority of the patients thought that their disorders could develop into colitis (43%) or cancer (21%).”
BackgroundFunctional GI disorders: from animal models to drug development
Mayer, E. A., Bradesi, S., Chang, L., Spiegel, B. M. R., Bueller, J. A., & Naliboff, B. D. (2008) · Gut · doi:10.1136/gut.2006.101675 · Cited by 162
Self-citationPsychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis
Person, H., & Keefer, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110209 · Cited by 158
van Tilburg, M. A. L., Palsson, O. S., & Whitehead, W. E. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.03.004 · Cited by 147
“Despite our best efforts to include the most relevant psychological variables we may have left out some important and/or newer concepts such as perceived stress [68,69], gastro-intestinal specific anxiety [70], anxiety sensitivity [19], alexithymia [68,71], or hypervigilance to symptoms [72,73].”
BackgroundPinto-Sanchez, M. I., Ford, A. C., Avila, C. A., Verdu, E. F., Collins, S. M., Morgan, D., Moayyedi, P., & Bercik, P. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.128 · Cited by 140
Ljótsson, B., Hesser, H., Andersson, E., Lackner, J. M., El Alaoui, S., Falk, L., Aspvall, K., Fransson, J., Hammarlund, K., Löfström, A., et al. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.01.007 · Cited by 141
Labus, J. S., Naliboff, B. N., Fallon, J., Berman, S. M., Suyenobu, B. Y., Bueller, J. A., Mandelkern, M. A., & Mayer, E. A. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.009 · Cited by 149
“Affected patients show frequent comorbidity with anxiety, (Mayer et al., 2001) as well as symptom-related anxiety (e.g. fears and worry over expected abdominal pain and discomfort (Labus et al., 2007)).”
BackgroundSelf-citationBonnert, M., Olén, O., Lalouni, M., Benninga, M. A., Bottai, M., Engelbrektsson, J., Hedman, E., Lenhard, F., Melin, B., Simrén, M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.503 · Cited by 139
Brief cognitive-behavioral internet therapy for irritable bowel syndrome
Hunt, M. G., Moshier, S., & Milonova, M. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.05.002 · Cited by 139
Ljótsson, B., Andersson, G., Andersson, E., Hedman, E., Lindfors, P., Andréewitch, S., Rück, C., & Lindefors, N. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-110 · Cited by 132
“Several studies have confirmed the impact of symptom-related fear and avoidance behaviors on symptom severity and quality of life in IBS [24,27-30].”
BackgroundCognitive-behavioral therapy for patients with irritable bowel syndrome: current insights
Kinsinger, S. (2017) · Psychology Research and Behavior Management · doi:10.2147/prbm.s120817 · Cited by 120
“23,24 Visceral anxiety refers to the fear of and hypervigilance to bowel symptoms and associated avoidance of situations where symptoms may occur.”
Zaman, J., Vlaeyen, J. W. S., Oudenhove, L. V., Wiech, K., & Diest, I. V. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.009 · Cited by 135
Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease
Taft, T., Triggs, J., Carlson, D. A., Guadagnoli, L. A., Tomasino, K. N., Keefer, L., & Pandolfino, J. E. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14605 · Cited by 129
SPIEGEL, B., BOLUS, R., HARRIS, L. A., LUCAK, S., NALIBOFF, B., ESRAILIAN, E., CHEY, W. D., LEMBO, A., KARSAN, H., TILLISCH, K., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04144.x · Cited by 112
Self-citationGlasinovic, E., Wynter, E., Arguero, J., Ooi, J., Nakagawa, K., Yazaki, E., Hajek, P., Psych, C. C., Woodland, P., & Sifrim, D. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.15 · Cited by 107
Hong, J.-Y., Kilpatrick, L. A., Labus, J., Gupta, A., Jiang, Z., Ashe-McNalley, C., Stains, J., Heendeniya, N., Ebrat, B., Smith, S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5733-12.2013 · Cited by 104
“…the Hospital Anxiety Depression (HAD) scale (Mykletun et al., 2001), IBS-related fears and anxiety using the Visceral Sensitivity Index (VSI; Labus et al., 2004; Labus et al., 2007), and the big five personality traits using the NEO Personality Inventory-Revised (NEO PI-R; Costa and McCrae, 1995).”
MethodSelf-citationSPIEGEL, B., SCHOENFELD, P., & NALIBOFF, B. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03357.x · Cited by 98
Self-citationHunt, M., Miguez, S., Dukas, B., Onwude, O., & White, S. (2021) · JMIR mHealth and uHealth · doi:10.2196/26152 · Cited by 98
“The Visceral Sensitivity Index (VSI) is a unidimensional 15-item scale that measures GI symptom–specific anxiety [6,37].”
BackgroundEffects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome
Patel, A., Hasak, S., Cassell, B. E., Ciorba, M. A., Vivio, E. E., Kumar, M., Gyawali, C. P., & Sayuk, G. S. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13677 · Cited by 111
Anxiety disorders and medical comorbidity: Treatment implications
Meuret, A. E., Tunnell, N., & Roque, A. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_15 · Cited by 96
Hong, J.-Y., Kilpatrick, L. A., Labus, J. S., Gupta, A., Katibian, D., Ashe-McNalley, C., Stains, J., Heendeniya, N., Smith, S. R., Tillisch, K., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1683-14.2014 · Cited by 92
“…anxiety depression scale (HAD); Mykletun et al., 2001], GI symptomspecific perception associated with prediction, fear, and worry [visceral sensitivity index (VSI); Labus et al., 2004, 2007], and intensity of GI symptoms over the past 24 h with using the Gracely pain scale (Heft et al., 1980).”
MethodSelf-citationPersonality traits and emotional patterns in irritable bowel syndrome
Muscatello, M. R. A., Bruno, A., Mento, C., Pandolfo, G., & Zoccali, R. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i28.6402 · Cited by 102
Anxiety and depression in various functional gastrointestinal disorders: Do differences exist?
HARTONO, J. L., MAHADEVA, S., & GOH, K. (2012) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2012.00581.x · Cited by 92
Mechanisms of change in an exposure-based treatment for irritable bowel syndrome.
Ljótsson, B., Hesser, H., Andersson, E., Lindfors, P., Hursti, T., Rück, C., Lindefors, N., Andersson, G., & Hedman, E. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0033439 · Cited by 94
Keefer, L., Bedell, A., Norton, C. S., & Hart, A. L. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.08.060 · Cited by 95
Mediation Analysis in Psychosomatic Medicine Research
Lockhart, G., MacKinnon, D. P., & Ohlrich, V. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318200a54b · Cited by 87
“Hoyle RH, Kenny DA.”
BackgroundInfluentialRingström, G., Störsrud, S., Posserud, I., Lundqvist, S., Westman, B., & Simrén, M. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283333b61 · Cited by 85
Sex-Related Differences of Cortical Thickness in Patients with Chronic Abdominal Pain
Jiang, Z., Dinov, I. D., Labus, J., Shi, Y., Zamanyan, A., Gupta, A., Ashe-McNalley, C., Hong, J.-Y., Tillisch, K., Toga, A. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073932 · Cited by 81
“Affected patients present with chronically recurrent abdominal pain and discomfort associated with altered bowel habits, and increased levels of anxiety [7], symptom-related anxiety [8], and catastrophizing [9].”
BackgroundSelf-citationVan Oudenhove, L., Vandenberghe, J., Demyttenaere, K., & Tack, J. (2010) · Digestion · doi:10.1159/000269822 · Cited by 74
Knowles, S. R., Austin, D. W., Sivanesan, S., Tye-Din, J., Leung, C., Wilson, J., Castle, D., Kamm, M. A., Macrae, F., & Hebbard, G. (2017) · Psychology, Health & Medicine · doi:10.1080/13548506.2016.1168932 · Cited by 71
“Consistent with Labus and colleagues (Labus et al., 2004, 2007) final model also provides further evidence for the important role of visceral sensitivity in IBS.”
BackgroundExposure and mindfulness based therapy for irritable bowel syndrome - An open pilot study
Ljótsson, B., Andréewitch, S., Hedman, E., Rück, C., Andersson, G., & Lindefors, N. (2010) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2010.01.001 · Cited by 76
“The VSI has good psychometric properties and has been shown to be a key explanatory variable of IBS diagnostic status (Labus et al., 2007).”
BackgroundSpiegel, B., Camilleri, M., Bolus, R., Andresen, V., Chey, W. D., Fehnel, S., Mangel, A., Talley, N. J., & Whitehead, W. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.047 · Cited by 75
Self-citationÖhman, L., Stridsberg, M., Isaksson, S., Jerlstad, P., & Simrén, M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.458 · Cited by 74
Labus, J. S., Naliboff, B. D., Berman, S. M., Suyenobu, B., Vianna, E. P., Tillisch, K., & Mayer, E. A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.078 · Cited by 71
“, 2001) as well as disease-related anxiety (Labus et al., 2007).”
BackgroundSelf-citationHong, J.-Y., Labus, J. S., Jiang, Z., Ashe-Mcnalley, C., Dinov, I., Gupta, A., Shi, Y., Stains, J., Heendeniya, N., Smith, S. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084564 · Cited by 67
“Questionnaires were completed before scanning to determine symptom type, severity, duration of symptoms, and abdominal sensation (UCLA Bowel Symptom Questionnaire, BSQ) [24], comorbid affective and mood disorders (Hospital Anxiety Depression Scale, HAD) [25], and IBS-related fears and anxiety (Visceral Sensitivity Ind…”
BackgroundSelf-citationYadlapati, R. H., Pandolfino, J. E., Lidder, A. K., Shabeeb, N., Jaiyeola, D.-M., Adkins, C., Agrawal, N., Cooper, A., Price, C. P. E., Ciolino, J. D., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.145 · Cited by 70
Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome
Goodoory, V. C., Mikocka-Walus, A., Yiannakou, Y., Houghton, L. A., Black, C. J., & Ford, A. C. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001247 · Cited by 64
Systematic review: instruments to assess abdominal pain in irritable bowel syndrome
Mujagic, Z., Keszthelyi, D., Aziz, Q., Reinisch, W., Quetglas, E. G., Leonardis, F. D., Segerdahl, M., & Masclee, A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13378 · Cited by 70
Hong, J. ‐., Naliboff, B., Labus, J. S., Gupta, A., Kilpatrick, L. A., Ashe‐McNalley, C., Stains, J., Heendeniya, N., Smith, S. R., Tillisch, K., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12710 · Cited by 63
Self-citationKearney, D. J., McDermott, K., Martinez, M., & Simpson, T. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04731.x · Cited by 63
“The effectiveness of cognitive behavioural therapy for IBS is diminished when there are high levels of baseline depression or anxiety.18–20 Overall, the treatment options for IBS are generally unsatisfactory; approximately one-third of patients do not achieve adequate response with existing treatments.8 The lack of pa…”
BackgroundInfluentialVisceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome
Wolitzky-Taylor, K., Craske, M. G., Labus, J. S., Mayer, E. A., & Naliboff, B. D. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2012.05.010 · Cited by 62
“P A A uthor M anuscript validity (Labus et al., 2004; Labus et al., 2007).”
Self-citationMidenfjord, I., Borg, A., Törnblom, H., & Simrén, M. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001038 · Cited by 57
Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome
Berman, S., Suyenobu, B., Naliboff, B. D., Bueller, J., Stains, J., Wong, H., Mandelkern, M., Fitzgerald, L., Ohning, G., Gupta, A., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.028 · Cited by 59
“During screening, patients completed the UCLA Bowel Symptom Questionnaire (BSQ) (Munakata et al., 1997), the Eysenck Personality Questionnaire-Revised (EPQR) (Eysenck and Eysenck, 1994), the Visceral Sensitivity Index (VSI) (Labus et al., 2007), the Hospital Anxiety and Depression Index (HAD) (Farhadi et al., 2001), a…”
InfluentialSelf-citationIrritable Bowel Syndrome: Current Approach to Symptoms, Evaluation, and Treatment
Videlock, E. J., & Chang, L. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.07.002 · Cited by 65
Self-citationHypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease
Posserud, I., Svedlund, J., Wallin, J., & Simrén, M. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.09.020 · Cited by 64
“GI-specific anxiety is associated with IBS symptom severity [34,35], and a high prevalence of somatisation associated with health anxiety has been demonstrated in IBS indicating an increased awareness of and concern about bodily sensations [7].”
BackgroundAlexithymia in Gastroenterology and Hepatology: A Systematic Review
Carrozzino, D., & Porcelli, P. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00470 · Cited by 54
“However, TAS-20 alone explained 54% of the IBS severity score variance, to which GSA added a smaller although significant amount of 9%.”
BackgroundInfluentialBonnert, M., Olén, O., Lalouni, M., Hedman-Lagerlöf, E., Särnholm, J., Serlachius, E., & Ljótsson, B. (2019) · Behavior Therapy · doi:10.1016/j.beth.2018.05.002 · Cited by 53
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern
Su, A. M., Shih, W., Presson, A. P., & Chang, L. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12220 · Cited by 53
Self-citationInfluence of Interoceptive Fear Learning on Visceral Perception
Zaman, J., Weltens, N., Ly, H. G., Struyf, D., Vlaeyen, J. W. S., Van den Bergh, O., Wiech, K., Van Oudenhove, L., & Van Diest, I. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000257 · Cited by 56
“(10), gastrointestinal symptom–specific anxiety is “the cognitive, affective, and behavioral response stemming from fear of gastro-intestinal sensations, symptoms, and the context in which these visceral sensations and symptoms occur.”
Cognitive behavioral approach to understanding irritable bowel syndrome
Hauser, G., Pletikosić, S., & Tkalčić, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6744 · Cited by 60
Bonnert, M., Olén, O., Bjureberg, J., Lalouni, M., Hedman-Lagerlöf, E., Serlachius, E., & Ljótsson, B. (2018) · Behaviour Research and Therapy · doi:10.1016/j.brat.2018.03.006 · Cited by 53
Bessissow, T., Van Keerberghen, C.-A., Van Oudenhove, L., Ferrante, M., Vermeire, S., Rutgeerts, P., & Van Assche, G. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.04.011 · Cited by 53
Larussa, T., Suraci, E., Marasco, R., Imeneo, M., Abenavoli, L., & Luzza, F. (2019) · Medicina · doi:10.3390/medicina55080507 · Cited by 55
“Although the VSI questionnaire has been validated for irritable bowel syndrome (IBS), its use has been proposed as a measure of brain–gut interaction in other gastrointestinal conditions [26,32].”
BackgroundSaigo, T., Tayama, J., Hamaguchi, T., Nakaya, N., Tomiie, T., Bernick, P. J., Kanazawa, M., Labus, J. S., Naliboff, B. D., Shirabe, S., et al. (2014) · BioPsychoSocial Medicine · doi:10.1186/1751-0759-8-10 · Cited by 50
“Interventions aimed at reducing GSA associated with IBS should therefore contribute to an improvement in the QOL of patients with IBS [27,28].”
BackgroundResultSelf-citationGERD Symptoms in the General Population: Prevalence and Severity Versus Care-Seeking Patients
Cohen, E., Bolus, R., Khanna, D., Hays, R. D., Chang, L., Melmed, G. Y., Khanna, P., & Spiegel, B. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3181-8 · Cited by 51
“Applying the VSI to diverse subjects with GERD symptoms, we found that those with higher visceral anxiety also had higher adjusted GERD severity versus those with lower visceral anxiety.”
BackgroundMethodSelf-citationAddante, R. A., Naliboff, B. D., Shih, W., Presson, A. P., Tillisch, K., Mayer, E. A., & Chang, L. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000978 · Cited by 57
Self-citationAlexithymia and Physical Illness: A Psychosomatic Approach
Porcelli, P., & Taylor, G. J. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108241595.009 · Cited by 65
Understanding Gastrointestinal Distress: A Framework for Clinical Practice
Spiegel, B. M. R., Khanna, D., Bolus, R., Agarwal, N., Khanna, P., & Chang, L. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.383 · Cited by 51
Self-citationTwiss, C., Kilpatrick, L., Craske, M., Buffington, C. A. T., Ornitz, E., Rodríguez, L. V., Mayer, E. A., & Naliboff, B. D. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.01.025 · Cited by 47
“The examination of symptom specific anxiety warrants further study as a predictor of physiological responses like startle and autonomic responses, and may be an important target for treatment.(25,26) Several limitations to the study should be recognized.”
BackgroundSelf-citationLackner, J. M., Gudleski, G. D., Ma, C.-X., Dewanwala, A., & Naliboff, B. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.241 · Cited by 47
Self-citationAnxiety‐related factors associated with symptom severity in irritable bowel syndrome
Black, C. J., Yiannakou, Y., Houghton, L. A., Shuweihdi, F., West, R., Guthrie, E., & Ford, A. C. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13872 · Cited by 48
Zucker, N. L., & Bulik, C. M. (2020) · International Journal of Eating Disorders · doi:10.1002/eat.23255 · Cited by 48
Grodzinsky, E., Walter, S., Viktorsson, L., Carlsson, A.-K., Jones, M. P., & Faresjö, Å. (2015) · BMC Family Practice · doi:10.1186/s12875-015-0225-x · Cited by 49
“fear of symptoms and behavioral pattern of control and avoidance, is associated with decreased quality of life as well as worsening symptoms [54,55].”
BackgroundLackner, J. M., Gudleski, G. D., DiMuro, J., Keefer, L., & Brenner, D. M. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.03.001 · Cited by 49
Increased Acoustic Startle Responses in IBS Patients During Abdominal and Nonabdominal Threat
Naliboff, B. D., Waters, A. M., Labus, J. S., Kilpatrick, L., Craske, M. G., Chang, L., Negoro, H., Ibrahimovic, H., Mayer, E. A., & Ornitz, E. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318186d858 · Cited by 45
“Although by questionnaire, IBS patients show evidence for visceral specific anxiety, (4) in this study the IBS group showed similar startle potentiation to both the abdominal and nonabdominal threat conditions.”
BackgroundSelf-citationLackner, J., Jaccard, J., Baum, C., Smith, A., Krasner, S., Katz, L., Firth, R., Raby, T., & Powell, C. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.06.014 · Cited by 44
Ferreira, N. B., Gillanders, D., Morris, P. G., & Eugenicos, M. (2018) · Clinical Psychologist · doi:10.1111/cp.12123 · Cited by 44
“GSA is a key feature in IBS symptom maintenance, by acting as an endogenous stressor, and higher levels of GSA have consistently been shown to be related to higher symptom severity and lower quality of life (Jerndal et al., 2010; Labus et al., 2004, 2007).”
BackgroundInfluentialAlexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome
Porcelli, P., Carne, M. D., & Leandro, G. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.05.022 · Cited by 48
“It measures five different dimensions of GIrelated cognitions and behaviors (fear, worry, vigilance, sensitivity, and avoidance) and has shown excellent psychometric properties, including concurrent, divergent, and discriminant validity [11].”
BackgroundMethodResultInfluentialPorcelli, P., Carne, M. D., & Leandro, G. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.11.010 · Cited by 48
Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
Lövdahl, J., Törnblom, H., Ringström, G., Palsson, O. S., & Simrén, M. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16934 · Cited by 43
“Moderate (score 176– 299), n (%) 20 (33) 18 (31)”
Cassar, G. E., Knowles, S., Youssef, G. J., Moulding, R., Uiterwijk, D., Waters, L., & Austin, D. W. (2018) · Psychology, Health & Medicine · doi:10.1080/13548506.2018.1476722 · Cited by 40
“Consistent with past research, we found that increased symptom frequency was associated with increased visceral sensitivity, distress, and pain catastrophization, as well as poorer QoL (Jerndal et al., 2010; Knowles et al., 2016; Labus et al., 2007; Lackner et al., 2014; Saigo et al., 2014).”
BackgroundResultNevé, B. L., Posserud, I., Böhn, L., Guyonnet, D., Rondeau, P., Tillisch, K., Naliboff, B. D., Mayer, E. A., & Simrén, M. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.75 · Cited by 43
Self-citationWang, Z., Bradesi, S., Charles, J. R., Pang, R. D., Maarek, J. I., Mayer, E. A., & Holschneider, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.08.022 · Cited by 41
“Symptom-related anxiety and maladaptive coping (e.g., catastrophizing, worst-case assumption of pain outcomes) play a prominent role in the pathophysiology of persistent pain disorders, including irritable bowel syndrome (IBS) [8,28,67].”
Self-citationWilpart, K., Törnblom, H., Svedlund, J., Tack, J. F., Simrén, M., & Oudenhove, L. V. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.032 · Cited by 42
Trieschmann, K. D., Chang, L., Park, S. H., Naliboff, B. D., Joshi, S. M., Labus, J. S., Sauk, J. S., Limketkai, B. N., & Mayer, E. A. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14384 · Cited by 44
Self-citationHenrich, J. F., Knittle, K. P., Gucht, V. D., Warren, S., Dombrowski, S. U., & Maes, S. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.12.009 · Cited by 44
“Therefore, when possible, interventions should be delivered in a manner consistent with an individual’s illness or treatment beliefs [89], as this can increase feelings of self-efficacy and illness control which are associated with symptom improvement [85,90] .”
BackgroundBrain-based Correlations Between Psychological Factors and Functional Dyspepsia
Nan, J., Liu, J., Mu, J., Dun, W., Zhang, M., Gong, Q., Qin, W., Tian, J., Liang, F., & Zeng, F. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14096 · Cited by 42
Modulating interoception by insula stimulation: A double-blinded tDCS study
Sagliano, L., Magliacano, A., Parazzini, M., Fiocchi, S., Trojano, L., & Grossi, D. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.022 · Cited by 39
Santucci, N. R., King, C. D., El‐Chammas, K. I., Wongteerasut, A., Damrongmanee, A., Graham, K. D., Fei, L., Sahay, R. D., Jones, C., Cunningham, N. R., et al. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14358 · Cited by 37
Spiegel, B. M. R., Bolus, R., Harris, L. A., Lucak, S., Chey, W. D., Sayuk, G., Esrailian, E., Lembo, A., Karsan, H., Tillisch, K., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04443.x · Cited by 35
Self-citationSebastián Sánchez, B., Gil Roales-Nieto, J., Ferreira, N. B., Gil Luciano, B., & Sebastián Domingo, J. J. (2017) · Revista Espanola de Enfermedades Digestivas · doi:10.17235/reed.2017.4660/2016 · Cited by 36
“The literature has shown that higher levels of GSA are related to higher symptom severity and lower quality of life in IBS (37,39,40).”
BackgroundFarmer, A. D., Ruffle, J. K., & Hobson, A. R. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13492 · Cited by 37
Development of Irritable Bowel Syndrome Features Over a 5-year Period
Clevers, E., Tack, J., Törnblom, H., Ringström, G., Luyckx, K., Simrén, M., & Van Oudenhove, L. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.02.043 · Cited by 34
Khanna, P. P., Agarwal, N., Khanna, D., Hays, R. D., Chang, L., Bolus, R. R., Melmed, G., Whitman, C. B., Kaplan, R. M., Ogawa, R. S., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.401 · Cited by 37
Self-citationRingström, G., Störsrud, S., & Simrén, M. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328354f41f · Cited by 31
Tziallas, D., Kostapanos, M. S., Skapinakis, P., Milionis, H. J., Athanasiou, T., Elisaf, M., & Mavreas, V. G. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-105 · Cited by 32
More similarities than differences between men and women with irritable bowel syndrome
Björkman, I., Jakobsson Ung, E., Ringström, G., Törnblom, H., & Simrén, M. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12551 · Cited by 30
Metadata
- Authors
- Labus, J. S., Mayer, E. A., Chang, L., Bolus, R., & Naliboff, B. D.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Labus, Jennifer S.
- Venue
- Psychosomatic Medicine
- Published
- 2007-01
- Volume
- 69
- Issue
- 1
- Pages
- 89-98
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2031167188
- Cited by
- 257
- References
- 52
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 12 · 2023: 12 · 2022: 21 · 2021: 21 · 2020: 17 · 2019: 7 · 2018: 23 · 2017: 11 · 2016: 14 · 2015: 10 · 2014: 18 · 2013: 12 · 2012: 8
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r01nr004881-03)
- National Institute of Nursing Research (NR-04881)
- National Institute of Diabetes and Digestive and Kidney Diseases (P50DK064539, P-50DK64539)
- National Center for Complementary and Integrative Health (R24AT002681)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- irritable bowel syndrome, psychometric validation, anxiety sensitivity, psychological distress, known-groups validity, visceral sensation, health care utilization, depression
- MeSH terms
- Adolescent, Adult, Anxiety, Cognition, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Psychometrics, Reproducibility of Results, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.